Clinical Effect of Platelet Rich Plasma Combined With Laser on Scar
NCT ID: NCT02396290
Last Updated: 2015-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2013-03-31
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Picosecond Pulsed Nd:YAG Laser and Fractional Laser for the Treatment of Acne Scars
NCT03850925
The Efficacy of Combination Therapy in Atrophic Scars
NCT06298591
Fractional CO2 Laser Combined With PRP Fluid Versus Gel in Treatment of Acne Scars
NCT04580758
Comparison of Efficacy Between Fractional Microneedling Radiofrequency and Bipolar Radiofrequency for Acne Scar
NCT02207738
Comparison of the Efficacy of Fractional Er:YAG Laser for Acne Scar
NCT01958450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fractional CO2 laser with PRP
fractional carbon dioxide laser followed by intradermal injection of platelet rich plasma
fractional carbon dioxide laser with platelet rich plasma
fractional carbon dioxide laser followed by platelet rich plasma injection
fractional CO2 laser with NS
fractional carbon dioxide laser followed by intradermal injection of NS
fractional carbon dioxide laser with NS
fractional carbon dioxide laser followed by normal saline injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fractional carbon dioxide laser with platelet rich plasma
fractional carbon dioxide laser followed by platelet rich plasma injection
fractional carbon dioxide laser with NS
fractional carbon dioxide laser followed by normal saline injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* underlying diabetes mellitus, keloid, or malignancy
19 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dae Hun Suh, PhD
Role: STUDY_CHAIR
Department of Dermatology, Seoul National University College of Medicine
Seonguk Min, Msc
Role: PRINCIPAL_INVESTIGATOR
Department of Dermatology, Seoul National University College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dermatology, Seoul National University College of Medicine
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tierney EP, Eisen RF, Hanke CW. Fractionated CO2 laser skin rejuvenation. Dermatol Ther. 2011 Jan-Feb;24(1):41-53. doi: 10.1111/j.1529-8019.2010.01377.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-0998
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.